Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Int J Infect Dis ; 122: 647-655, 2022 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-35809857

RESUMEN

BACKGROUND: Following an outbreak of cases of vesicular-pustular rash with fever, evocative of human monkeypox, in Bas-Uélé province, Democratic Republic of Congo, surveillance was strengthened. METHODS: Households with at least one active generalized vesicular-pustular rash case were visited, and contact and clinical history information were collected from all household members. Whenever possible, skin lesions were screened by polymerase chain reaction for the monkeypox virus, followed by the varicella-zoster virus, when negative for the former. RESULTS: Polymerase chain reaction results were obtained for 77 suspected cases, distributed in 138 households, of which 27.3% were positive for monkeypox, 58.4% positive for chickenpox, and 14.3% negative for both. Confirmed monkeypox cases presented more often with monomorphic skin lesions on the palms of the hands and on the soles of the feet. Integrating these three features into the case definition raised the specificity to 85% but would miss 50% of true monkeypox cases. A predictive model fit on patient demographics and symptoms had 97% specificity and 80% sensitivity but only 80% and 33% in predicting out-of-sample cases. CONCLUSION: Few discriminating features were identified and the performance of clinical case definitions was suboptimal. Rapid field diagnostics are needed to optimize worldwide early detection and surveillance of monkeypox.


Asunto(s)
Varicela , Exantema , Mpox , Varicela/diagnóstico , Varicela/epidemiología , República Democrática del Congo/epidemiología , Humanos , Mpox/diagnóstico , Mpox/epidemiología , Monkeypox virus/genética
2.
Emerg Infect Dis ; 26(9): 2205-2209, 2020 09.
Artículo en Inglés | MEDLINE | ID: mdl-32818404

RESUMEN

After the 2017 Ebola virus (EBOV) outbreak in Likati, a district in northern Democratic Republic of the Congo, we sampled small mammals from the location where the primary case-patient presumably acquired the infection. None tested positive for EBOV RNA or antibodies against EBOV, highlighting the ongoing challenge in detecting animal reservoirs for EBOV.


Asunto(s)
Ebolavirus , Fiebre Hemorrágica Ebola , Animales , Animales Salvajes , República Democrática del Congo/epidemiología , Brotes de Enfermedades , Ebolavirus/genética , Fiebre Hemorrágica Ebola/epidemiología , Humanos
3.
Int J Infect Dis ; 79: 187-194, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30711145

RESUMEN

OBJECTIVES: To investigate the reasons for the high prevalence of epilepsy (>6%) discovered in 2015 in the Aketi health zone in the north of the Democratic Republic of the Congo. METHODS: Persons with epilepsy (PWE) diagnosed in a door-to-door survey in 2015 were traced and re-examined in 2017 by a neurologist. Confirmed PWE were paired with matched controls. For onchocerciasis assessment, children 7-10 years old were tested for IgG4 Onchocerca volvulus (OV16) antibodies, a rapid epidemiological mapping of onchocerciasis (REMO) study was performed, and ivermectin coverage was investigated. RESULTS: Forty-three (61.4%) previously diagnosed PWE were traced; the neurologist confirmed the epilepsy diagnosis in all of them. The overall OV16 positivity rate was 64.5%. Poor ivermectin coverage (55.9%) and a high prevalence of onchocercal nodules (>70%) were observed. The prevalence of epilepsy was 5.7% in Aketi rural town, with nine PWE (13.8%) experiencing head nodding seizures. A case-control study showed that PWE had lower body weight and higher ivermectin coverage in 2017 than healthy controls. CONCLUSIONS: The high prevalence of epilepsy in the Aketi health zone, despite 14 years of community-directed treatment with ivermectin (CDTI), was found to be associated with high onchocerciasis transmission and low ivermectin use. An awareness programme to increase ivermectin coverage and the introduction of a bi-annual CDTI programme should be considered.


Asunto(s)
Epilepsia/epidemiología , Ivermectina/uso terapéutico , Oncocercosis/epidemiología , Adolescente , Adulto , Animales , Anticuerpos Antihelmínticos/sangre , Estudios de Casos y Controles , Niño , Preescolar , República Democrática del Congo/epidemiología , Femenino , Grupos Focales , Humanos , Inmunoglobulina G/sangre , Masculino , Onchocerca volvulus/aislamiento & purificación , Oncocercosis/tratamiento farmacológico , Prevalencia , Población Rural , Convulsiones/epidemiología , Adulto Joven
4.
PLoS One ; 13(3): e0194276, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29538437

RESUMEN

In 2013, a large measles epidemic occurred in the Aketi Health Zone of the Democratic Republic of Congo. We conducted a two-stage, retrospective cluster survey to estimate the attack rate, the case fatality rate, and the measles-specific mortality rate during the epidemic. 1424 households containing 7880 individuals were included. The estimated attack rate was 14.0%, (35.0% among children aged <5 years). The estimated case fatality rate was 4.2% (6.1% among children aged <5 years). Spatial analysis and linear regression showed that younger children, those who did not receive care, and those living farther away from Aketi Hospital early in the epidemic had a higher risk of measles related death. Vaccination coverage prior to the outbreak was low (76%), and a delayed reactive vaccination campaign contributed to the high attack rate. We provide evidences suggesting that a comprehensive case management approach reduced measles fatality during this epidemic in rural, inaccessible resource-poor setting.


Asunto(s)
Manejo de Caso , Brotes de Enfermedades , Sarampión/epidemiología , Adolescente , Niño , Preescolar , República Democrática del Congo/epidemiología , Epidemias , Femenino , Historia del Siglo XXI , Humanos , Lactante , Recién Nacido , Masculino , Sarampión/historia , Sarampión/mortalidad , Sarampión/prevención & control , Mortalidad , Vigilancia de la Población , Factores de Riesgo , Cobertura de Vacunación , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...